niacinamide has been researched along with Autoimmune Disease in 12 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of bullous pemphigoid responding to niacinamide as monotherapy is reported." | 3.70 | Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide. ( Elston, DM; Honl, BA, 1998) |
| "A combination of niacinamide and tetracycline was used to treat 31 dogs with various autoimmune skin diseases (discoid lupus erythematosus, pemphigus foliaceus, pemphigus erythematosus, and bullous pemphigoid)." | 3.68 | Use of tetracycline and niacinamide for treatment of autoimmune skin disease in 31 dogs. ( Paradis, M; Reinke, SI; Rosychuk, RA; White, SD, 1992) |
| "Nicotinamide prevents autoimmune diabetes in animal models, possibly through inhibition of the DNA repair enzyme poly-ADP-ribose polymerase and prevention of beta-cell NAD depletion." | 2.71 | European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. ( Bingley, PJ; Collier, T; Emmett, CL; Gale, EA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, AC | 1 |
| Damian, DL | 1 |
| Simmons, K | 1 |
| Michels, AW | 1 |
| Gale, EA | 1 |
| Bingley, PJ | 1 |
| Emmett, CL | 1 |
| Collier, T | 1 |
| Penberthy, WT | 1 |
| Honl, BA | 1 |
| Elston, DM | 1 |
| Palmer, JP | 1 |
| Cutshall, NS | 1 |
| Ursino, R | 1 |
| Kucera, KA | 1 |
| Latham, J | 1 |
| Ihle, NC | 1 |
| White, SD | 1 |
| Rosychuk, RA | 1 |
| Reinke, SI | 1 |
| Paradis, M | 1 |
| Oranje, AP | 1 |
| Vuzevski, VD | 1 |
| van Joost, T | 1 |
| ten Kate, F | 1 |
| Naafs, B | 1 |
| Herskowitz, RD | 1 |
| Jackson, RA | 1 |
| Soeldner, JS | 1 |
| Eisenbarth, GS | 1 |
| Hermitte, L | 1 |
| Vialettes, B | 1 |
| Atlef, N | 1 |
| Payan, MJ | 1 |
| Doll, N | 1 |
| Scheimann, A | 1 |
| Vague, P | 1 |
| Tochino, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| TrialNet Pathway to Prevention of T1D[NCT00097292] | 75,000 participants (Anticipated) | Observational | 2004-02-29 | Recruiting | |||
| Comparison of Nicotinamide and Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients[NCT01011699] | Phase 3 | 176 participants (Actual) | Interventional | 2010-01-31 | Terminated (stopped due to Financial problem) | ||
| Randomized Double-blinded Comparative Trial to Study the Add-on Activity of Combination Treatment of Nicotinamide on Progression Free Survival for EGFR Mutated Lung Cancer Terminal Stage Patients Being Treated With Gefitinib or Erlotinib[NCT02416739] | Phase 2/Phase 3 | 110 participants (Actual) | Interventional | 2015-03-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for niacinamide and Autoimmune Disease
| Article | Year |
|---|---|
Nicotinamide and the skin.
Topics: Acne Vulgaris; Animals; Autoimmune Diseases; Carcinogenesis; Dermatitis, Atopic; Humans; Keratosis, | 2014 |
Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.
Topics: Abatacept; Antibodies, Monoclonal, Humanized; Autoantibodies; Autoimmune Diseases; Diabetes Mellitus | 2014 |
Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease.
Topics: Animals; Autoimmune Diseases; Humans; Immune Tolerance; Indoleamine-Pyrrole 2,3,-Dioxygenase; NAD; N | 2007 |
The NOD mouse as a model of type I diabetes.
Topics: Animals; Autoimmune Diseases; Diabetes Mellitus, Experimental; Female; Gonadal Steroid Hormones; Imm | 1987 |
1 trial available for niacinamide and Autoimmune Disease
| Article | Year |
|---|---|
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
Topics: Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Double-Blind Method; Europe; | 2004 |
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
Topics: Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Double-Blind Method; Europe; | 2004 |
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
Topics: Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Double-Blind Method; Europe; | 2004 |
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
Topics: Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Double-Blind Method; Europe; | 2004 |
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
Topics: Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Double-Blind Method; Europe; | 2004 |
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
Topics: Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Double-Blind Method; Europe; | 2004 |
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
Topics: Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Double-Blind Method; Europe; | 2004 |
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
Topics: Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Double-Blind Method; Europe; | 2004 |
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
Topics: Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Double-Blind Method; Europe; | 2004 |
7 other studies available for niacinamide and Autoimmune Disease
| Article | Year |
|---|---|
Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide.
Topics: Autoimmune Diseases; Breast Diseases; Dermatologic Agents; Diagnosis, Differential; Female; Humans; | 1998 |
Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse.
Topics: Adoptive Transfer; Adult; Animals; Autoantibodies; Autoimmune Diseases; Cell Transplantation; Clinic | 2001 |
Nicotinamide N-oxides as CXCR2 antagonists.
Topics: Autoimmune Diseases; Binding Sites; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Chemotaxi | 2001 |
Use of tetracycline and niacinamide for treatment of autoimmune skin disease in 31 dogs.
Topics: Animals; Autoimmune Diseases; Dog Diseases; Dogs; Drug Combinations; Female; Lupus Erythematosus, Di | 1992 |
Bullous pemphigoid in children. Report of three cases with special emphasis on therapy.
Topics: Adolescent; Autoimmune Diseases; Child; Drug Therapy, Combination; Erythromycin; Humans; Male; Niaci | 1991 |
Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide.
Topics: Administration, Oral; Autoantibodies; Autoimmune Diseases; Diabetes Mellitus, Type 1; Drug Evaluatio | 1989 |
High dose nicotinamide fails to prevent diabetes in BB rats.
Topics: Age Factors; Animals; Autoimmune Diseases; Blood Glucose; Cyclosporine; Deferoxamine; Diabetes Melli | 1989 |